The Prevalence of Single and Multiple Thyroid Nodules and Its Association with Metabolic Diseases in Chinese: A Cross-Sectional Study

Table 7

Association between metabolic diseases and multiple thyroid nodules in female subjects analyzed by univariable logistic regression (N = 1368).

Factors	β	SE	Walds	value	OR	95% CI
Age
18–40				1.0	1.0 (ref)
41–50	0.23	0.17	1.84	0.18	1.26	0.90–1.77
51–60	0.44	0.18	6.06	0.01	1.55	1.09–2.19
61–70	0.68	0.22	9.40	<0.01	1.98	1.28–3.06
>70	1.32	0.42	9.98	<0.01	3.75	1.65–8.52
BMI
18.5∼23.99				1.0	1.0 (ref)
24∼7.9	0.13	0.14	0.97	0.33	1.14	0.88–1.49
≥28	−0.03	0.22	0.02	0.88	0.97	0.63–1.48
Central obesity	0.20	0.12	2.56	0.11	1.22	0.96–1.55
High TG	0.10	0.15	0.41	0.52	1.10	0.82–1.47
High TC	−0.00	0.16	0.00	0.98	1.00	0.73–1.35
High LDL-C	0.51	0.17	9.09	<0.01	1.67	1.20–2.32
Low HDL-C	−1.02	0.48	4.52	0.03	0.36	0.14–0.92
Normal blood sugar				1.0	1.0 (ref)
IGR	0.20	0.13	2.41	0.12	1.23	0.95–1.52
DM	0.03	0.17	0.03	0.87	1.03	0.73–1.45
HUA	0.37	0.15	6.22	0.01	1.44	1.08–1.92
MS	−0.14	0.18	0.61	0.43	0.87	0.60–1.24
Fatty liver	0.03	0.16	0.40	0.84	1.03	0.76–1.41

Note: BMI: body mass index; TG: triglyceride; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; IGR: sugar adjustment; DM: diabetes mellitus; HUA: hyperuricemia; MS: metabolic syndrome.